StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.37−0.12 (-2.19%)

Close on Nov 19, 2026Market cap $8.69MP/E –Yield –

Kazia Therapeutics r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was A$7.33M, down 57.8% from the year before. The highest annual figure on record is A$20.17M in fiscal 2022.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Jun 30, 2025A$7.33M-57.8%
FY2024Jun 30, 2024A$17.38M+11.7%
FY2023Jun 30, 2023A$15.56M-22.8%
FY2022Jun 30, 2022A$20.17M+38.7%
FY2021Jun 30, 2021A$14.54M+53.2%
FY2020Jun 30, 2020A$9.49M+46.6%
FY2019Jun 30, 2019A$6.48M-33.8%
FY2018Jun 30, 2018A$9.77M-12.2%
FY2017Jun 30, 2017A$11.14M+12.6%
FY2016Jun 30, 2016A$9.89M–

More Kazia Therapeutics figures

See a number that looks wrong?